DNA beta-polymerase (beta-pol) carries out two critical enzymatic reactions in mammalian single-
nucleotide base excision repair (BER):
DNA synthesis to fill the repair patch and
lyase removal of the 5'-deoxyribose
phosphate (dRP) group following cleavage of the abasic site by apurinic/apyrimidinic (
AP) endonuclease (1). The requirement for beta-pol in single-
nucleotide BER is exemplified in mouse fibroblasts with a null mutation in the beta-pol gene. These cells are hypersensitive to monofunctional
DNA methylating agents such as methyl methane-sulfonate (MMS) (2). This
hypersensitivity is associated with an abundance of chromosomal damage and induction of apoptosis and necrotic cell death (3). We have found that beta-pol null cells are defective in repair of MMS-induced DNA lesions, consistent with a cellular BER deficiency as a causative agent in the observed
hypersensitivity. Further, the N-terminal 8-kDa domain of beta-pol, which contains the
dRP lyase activity in the wild-type
enzyme, is sufficient to reverse the methylating agent
hypersensitivity in beta-pol null cells. These results indicate that
lyase removal of the dRP group is a pivotal step in BER in vivo. Finally, we examined MMS-induced genomic
DNA mutagenesis in two isogenic mouse cell lines designed for study of the role of BER. MMS exposure strongly increases mutant frequency in beta-pol null cells, but not in wild-type cells. With MMS treatment, beta-pol null cells have a higher frequency of all six base-pair substitutions, suggesting that BER plays a role in protecting the cell against methylation-induced mutations.